Breast cancer screening for carriers of ATM, CHEK2, and PALB2 pathogenic variants: A comparative modeling analysis.

被引:0
|
作者
Lowry, Kathryn P.
Geuzinge, H. Amarens
Stout, Natasha K.
Alagoz, Oguzhan
Hampton, John M.
Kerlikowske, Karla
Miglioretti, Diana L.
Schecter, Clyde
Sprague, Brian L.
Trentham-Dietz, Amy
Tosteson, Anna N. A.
Van Ravesteyn, Nicolien
Yaffe, Martin
Yeh, Jennifer
Couch, Fergus
Kraft, Peter
Polley, Eric
Mandelblatt, Jeanne S.
Kurian, Allison W.
Robson, Mark E.
机构
[1] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA
[2] Erasmus MC, Rotterdam, Netherlands
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
[5] Univ Wisconsin, Madison, WI USA
[6] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[7] Univ Calif San Francisco, San Francisco, CA 94143 USA
[8] Univ Calif Davis, Sch Med, Davis, CA USA
[9] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
[10] Univ Vermont, Burlington, VT USA
[11] Geisel Sch Med, Lebanon, NH USA
[12] Boston Childrens Hosp, Boston, MA USA
[13] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
[14] Mayo Clin, Harvard Sch Publ Hlth, Rochester, MN USA
[15] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[16] Stanford Sch Med, Stanford, CA 94305 USA
[17] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
10500
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants A Comparative Modeling Analysis
    Lowry, Kathryn P.
    Geuzinge, H. Amarens
    Stout, Natasha K.
    Alagoz, Oguzhan
    Hampton, John
    Kerlikowske, Karla
    de Koning, Harry J.
    Miglioretti, Diana L.
    van Ravesteyn, Nicolien T.
    Schechter, Clyde
    Sprague, Brian L.
    Tosteson, Anna N. A.
    Trentham-Dietz, Amy
    Weaver, Donald
    Yaffe, Martin J.
    Yeh, Jennifer M.
    Couch, Fergus J.
    Hu, Chunling
    Kraft, Peter
    Polley, Eric C.
    Mandelblatt, Jeanne S.
    Kurian, Allison W.
    Robson, Mark E.
    JAMA ONCOLOGY, 2022, 8 (04) : 587 - 596
  • [2] Clinicopathologic features of invasive breast cancer (BC) diagnosed in carriers of germline PALB2, CHEK2 and ATM pathogenic variants.
    Scott, Danika
    Kingham, Kerry
    Hodan, Rachel
    Ma, Cindy
    Mills, Meredith
    Ford, James M.
    Kurian, Allison W.
    Telli, Melinda L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model
    Lee, Andrew J.
    Cunningham, Alex P.
    Tischkowitz, Marc
    Simard, Jacques
    Pharoah, Paul D.
    Easton, Douglas F.
    Antoniou, Antonis C.
    GENETICS IN MEDICINE, 2016, 18 (12) : 1190 - 1198
  • [4] Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
    Yadav, Siddhartha
    Boddicker, Nicholas J.
    Na, Jie
    Polley, Eric C.
    Hu, Chunling
    Hart, Steven N.
    Gnanaolivu, Rohan D.
    Larson, Nicole
    Holtegaard, Susan
    Huang, Huaizhi
    Dunn, Carolyn A.
    Teras, Lauren R.
    Patel, Alpa V.
    Lacey, James V.
    Neuhausen, Susan L.
    Martinez, Elena
    Haiman, Christopher
    Chen, Fei
    Ruddy, Kathryn J.
    Olson, Janet E.
    John, Esther M.
    Kurian, Allison W.
    Sandler, Dale P.
    O'Brien, Katie M.
    Taylor, Jack A.
    Weinberg, Clarice R.
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Zirpoli, Gary
    Goldgar, David E.
    Palmer, Julie R.
    Domchek, Susan M.
    Weitzel, Jeffrey N.
    Nathanson, Katherine L.
    Kraft, Peter
    Couch, Fergus J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (09) : 1703 - +
  • [5] Real-world clinical characteristics and management of breast cancer in patients with germline pathogenic variants in ATM, CHEK2 and PALB2
    Brzeskiewicz, Laura
    Roscow, Breanna
    Beeks, April
    Kunz, Barb
    Ratzel, Sarah
    Slavin, Thomas
    Cummings, Shelly
    Tedesco, Karen
    Reid, Robert
    GENETICS IN MEDICINE, 2022, 24 (03) : S34 - S34
  • [6] Oncotype DX Breast Recurrence Score® analysis in early-stage breast cancer associated with CHEK2, ATM and PALB2 germline pathogenic variants
    Mustafayev, Fatma Akkoc
    Barrera, Angelica Gutierrez
    Liu, Diane
    Arun, Banu
    CANCER RESEARCH, 2024, 84 (09)
  • [7] PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
    Southey, Melissa C.
    Goldgar, David E.
    Winqvist, Robert
    Pylkas, Katri
    Couch, Fergus
    Tischkowitz, Marc
    Foulkes, William D.
    Dennis, Joe
    Michailidou, Kyriaki
    van Rensburg, Elizabeth J.
    Heikkinen, Tuomas
    Nevanlinna, Heli
    Hopper, John L.
    Doerk, Thilo
    Claes, Kathleen B. M.
    Reis-Filho, Jorge
    Teo, Zhi Ling
    Radice, Paolo
    Catucci, Irene
    Peterlongo, Paolo
    Tsimiklis, Helen
    Odefrey, Fabrice A.
    Dowty, James G.
    Schmidt, Marjanka K.
    Broeks, Annegien
    Hogervorst, Frans B.
    Verhoef, Senno
    Carpenter, Jane
    Clarke, Christine
    Scott, Rodney J.
    Fasching, Peter A.
    Haeberle, Lothar
    Ekici, Arif B.
    Beckmann, Matthias W.
    Peto, Julian
    dos-Santos-Silva, Isabel
    Fletcher, Olivia
    Johnson, Nichola
    Bolla, Manjeet K.
    Sawyer, Elinor J.
    Tomlinson, Ian
    Kerin, Michael J.
    Miller, Nicola
    Marme, Federik
    Burwinkel, Barbara
    Yang, Rongxi
    Guenel, Pascal
    Therese Truong
    Menegaux, Florence
    Sanchez, Marie
    JOURNAL OF MEDICAL GENETICS, 2016, 53 (12) : 800 - 811
  • [8] Factors that differentiate cancer risk management decisions among females with pathogenic/likely pathogenic variants in PALB2, CHEK2, and ATM
    Dean, Marleah
    Tezak, Ann L.
    Johnson, Sabrina
    Weidner, Anne
    Almanza, Deanna
    Pal, Tuya
    Cragun, Deborah L.
    GENETICS IN MEDICINE, 2023, 25 (11)
  • [9] Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations
    Colin Bergstrom
    Colton Pence
    Jordan Berg
    Natalia Partain
    Navid Sadeghi
    Caitlin Mauer
    Sara Pirzadeh-Miller
    Ang Gao
    Hsiao Li
    Nisha Unni
    Samira Syed
    Annals of Surgical Oncology, 2021, 28 : 3383 - 3393
  • [10] Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations
    Bergstrom, Colin
    Pence, Colton
    Berg, Jordan
    Partain, Natalia
    Sadeghi, Navid
    Mauer, Caitlin
    Pirzadeh-Miller, Sara
    Gao, Ang
    Li, Hsiao
    Unni, Nisha
    Syed, Samira
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 3383 - 3393